Table 2.
Classification of the Identified Types of NOD-Like Receptors (NLRs) and Their Main Activators
NLR | Main Activators |
---|---|
NLR A | |
CIITA | IFN-γ |
NLR B | |
NAIP1/2 | Injectisome |
NAIP5/6 | Flagellin |
NLR C | |
NOD1 (NLRC1) | Peptidoglycan iE-DAP |
NOD2 (NLRC2) | Peptidoglycan Muramyl dipeptide ssRNA |
NLRC3 | Undetermined |
IPAF (NLRC4) | Injectisome/flagellin (mediated by NAIPs) |
NLRC5 | IFNγ LPS Poly I:C |
NLRX1 | LPS Viral RNA |
NLRP | |
NLRP1 | Anthrax lethal toxin Toxoplasma gondii ATP depletion Muramyl dipeptide |
NLRP2 | LPS/TNF-α |
NLRP3 | K+ efflux Bacterial toxins and RNA Nigericin Aluminum hydroxide ATP Cholesterol and uric acid crystals Particulate matter Mitochondrial damage |
NLRP4 | Viral DNA/RNA |
NLRP5/8/13/14 | Undetermined |
NLRP6 | Viral RNA TLR ligands Lipotheicoic acid |
NLRP7 | Bacterial acylated lipoproteins Lysosomal proteases? K+ flux? |
NLRP9 | dsRNA |
NLRP10 | NOD1 activation |
NLRP11 | TLR4 ligands |
NLRP12 | ATP TLR2 ligands Yersinia pestis |
ATP = adenosine triphosphate; CIITA = major histocompatibility complex class II transactivator; iE-DAP = γ-D-glutamyl-meso-diaminopimelic acid; IFN = interferon; K = potassium; IPAF = interleukin-1b (IL-1b)-converting enzyme-protease-activating factor; LPS = lipopolysaccharide; NLR = nucleotide-binding oligomerization domain-like receptors; NAIP = Baculoviral IAP repeat-containing protein 1; NLRP = nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain-containing receptor; NOD1 = Nucleotide-binding oligomerization domain-containing protein 1; TNF = tumor necrosis factor; other abbreviations as in Table 1.